*Average Price as per 3 July, 2022
NO OF SHARES
PharmEasy is India’s largest digital healthcare platform, which operates an integrated, end-to-end business that aims to provide solutions for the healthcare needs of consumers across the following critical stages -
A. providing digital tools and information on illness and wellness,
B. offering teleconsultation,
C. offering diagnostics and radiology tests, and
D. delivering treatment protocols including products and devices.
PharmEasy has a presence across the country, with last-mile capabilities to deliver in over 18,587 pin codes (for June 2021) via PharmEasy marketplace, allowing us the ability to provide access in an affordable manner to the common man. Our platforms have scaled across urban, semi-urban and rural India, with an ability to serve people across income groups and geographies.
Pro Forma GMV was Rs. 78,654.84 million in Fiscal 2021 and Rs. 30,262.62 million, for three months ended June 30, 2021. Our Pro Forma GMV includes the GMV contribution from our acquisitions of Ascent, Medlife, Aknamed, and Thyrocare as if these were acquired on April 1, 2020.
The history of the equity share capital of Company is set forth below: